Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

927 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine.
Frey S, Dagan R, Ashur Y, Chen XQ, Ibarra J, Kollaritsch H, Mazur MH, Poland GA, Reisinger K, Walter E, Van Damme P, Braconier JH, Uhnoo I, Wahl M, Blatter MM, Clements D, Greenberg D, Jacobson RM, Norrby SR, Rowe M, Shouval D, Simmons SS, van Hattum J, Wennerholm S, Gress JO, et al. Frey S, et al. J Infect Dis. 1999 Dec;180(6):2018-22. doi: 10.1086/315119. J Infect Dis. 1999. PMID: 10558961 Clinical Trial.
Reply.
Frey S, Dagan R, Ashur Y, Chen XQ, Ibarra J, Kollaritsch H, Mazur MH, Poland GA, Reisinger K, Walter E, Van Damme P, Braconier JH, Uhnoo I I, Wahl M, Blatter MM, Clements D, Greenberg D, Jacobson RM, Norrby SR, Rowe M, Shouval D, Simmons SS, van Hattum J, Wennerholm S, O'Brien Gress J, Chan I I. Frey S, et al. J Infect Dis. 2000 Sep;182(3):1005-6. doi: 10.1086/315793. J Infect Dis. 2000. PMID: 10950808 No abstract available.
Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers.
Belshe RB, Stevens C, Gorse GJ, Buchbinder S, Weinhold K, Sheppard H, Stablein D, Self S, McNamara J, Frey S, Flores J, Excler JL, Klein M, Habib RE, Duliege AM, Harro C, Corey L, Keefer M, Mulligan M, Wright P, Celum C, Judson F, Mayer K, McKirnan D, Marmor M, Woody G; National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group and HIV Network for Prevention Trials (HIVNET). Belshe RB, et al. Among authors: frey s. J Infect Dis. 2001 May 1;183(9):1343-52. doi: 10.1086/319863. Epub 2001 Apr 10. J Infect Dis. 2001. PMID: 11294665 Clinical Trial.
Dose-related effects of smallpox vaccine.
Frey SE, Newman FK, Cruz J, Shelton WB, Tennant JM, Polach T, Rothman AL, Kennedy JS, Wolff M, Belshe RB, Ennis FA. Frey SE, et al. N Engl J Med. 2002 Apr 25;346(17):1275-80. doi: 10.1056/NEJMoa013431. Epub 2002 Mar 28. N Engl J Med. 2002. PMID: 11923489 Free article. Clinical Trial.
Dose-dependent neutralizing-antibody responses to vaccinia.
Belshe RB, Newman FK, Frey SE, Couch RB, Treanor JJ, Tacket CO, Yan L. Belshe RB, et al. J Infect Dis. 2004 Feb 1;189(3):493-7. doi: 10.1086/380906. Epub 2004 Jan 23. J Infect Dis. 2004. PMID: 14745707 Clinical Trial.
The immunogenetics of smallpox vaccination.
Stanley SL Jr, Frey SE, Taillon-Miller P, Guo J, Miller RD, Koboldt DC, Elashoff M, Christensen R, Saccone NL, Belshe RB. Stanley SL Jr, et al. J Infect Dis. 2007 Jul 15;196(2):212-9. doi: 10.1086/518794. Epub 2007 Jun 4. J Infect Dis. 2007. PMID: 17570108
927 results